| A Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers (NCT01002625) | Pfizer | 2009-11-01 |
| Muscle Malonyl Coa Biomarker Assay Development (NCT01003444) | Pfizer | 2009-11-01 |
| Study Of Celecoxib In Healthy Subjects (NCT00994461) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-11-01 |
| A Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0941 and the Effect of Food and Proton Pump Inhibition on GDC-0941 Tablet Pharmacokinetics in Healthy Volunteers (NCT00999128) | Genentech, Inc. | 2009-10-26 |
| Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers (NCT00991016) | Pfizer | 2009-10-01 |
| A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers (NCT00990015) | Pfizer | 2009-10-01 |
| AZD8683 Single Ascending Dose Study (NCT00979849) | AstraZeneca | 2009-10-01 |
| Neurochemical Modulation Cognitive Performance and Subjective Wellbeing In Healthy Controls (NCT02051153) | Cambridge University Hospitals NHS Foundation Trust | 2009-10-01 |
| Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients (NCT01135875) | University of Florida | 2009-10-01 |
| Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity (NCT00990223) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-10-01 |
| Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 Vaccine (NCT00995527) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-09-30 |
| Diet-Induced-Obesity Resistant Phenotypes in Humans (NCT00999154) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2009-09-19 |
| Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines (NCT01191853) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-09-18 |
| Safety Study of Tezepelumab (AMG 157) in Healthy Adults (NCT00972179) | Amgen | 2009-09-15 |
| Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies (NCT00995891) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-09-09 |
| Safety and Pharmacokinetics of ELB353 in Healthy Men (NCT00977886) | Biotie Therapies Corp. | 2009-09-01 |
| Relative Bioavailability Study of Solifenacin Succinate Liquid Suspension (Fed and Fasting) Versus VESIcare Tablet (Fasting) in Healthy Volunteers (NCT01015040) | Astellas Pharma Inc | 2009-09-01 |
| Epidemiology of Human Cytomegalovirus Excretion in the Saliva of Children Attending Nursery in France (NCT01704222) | University Hospital, Limoges | 2009-09-01 |
| A Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-03882845 In Healthy Volunteers (NCT00971802) | Pfizer | 2009-09-01 |
| Lung Deposition Via Different Inhalation Devices (NCT00975754) | AstraZeneca | 2009-09-01 |
| Safety, Tolerability and Pharmacokinetic Study of ASP1517 in Healthy Non-elderly Male Volunteers (NCT00978198) | Astellas Pharma Inc | 2009-09-01 |
| A Study to Determine the Effect of Food on the Pharmacokinetics of Abiraterone Acetate in Healthy Male Patients (NCT01798628) | Cougar Biotechnology, Inc. | 2009-09-01 |
| Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG) (NCT01311674) | Emergent BioSolutions | 2009-09-01 |
| Effect of Ambient Light on the Parameters of the Pupillary Light Reflex (NCT01207817) | University of Medicine and Dentistry of New Jersey | 2009-09-01 |
| A Midazolam Drug Interaction Study With PF-04171327 (NCT00987038) | Pfizer | 2009-09-01 |
| Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols (NCT00968084) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-08-06 |
| Oral Bioequivalence Study of PL 3100 and Naproxen in Healthy Adults (NCT00966641) | PLx Pharma | 2009-08-01 |
| Axitinib Pharmacokinetics in Chinese Healthy Volunteers (NCT00919204) | Pfizer | 2009-08-01 |
| A Novel Method of Preoxygenation Using a Bain Circuit (NCT00958178) | National Health Service, United Kingdom | 2009-08-01 |
| Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy Volunteers (NCT01327261) | University of Buenos Aires | 2009-08-01 |
| Pharmacokinetic Study of ABT-126 in Healthy Volunteers (NCT00959634) | Abbott | 2009-08-01 |
| Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral Tablet (NCT00950404) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-08-01 |
| Double-blind Placebo-controlled 2-part Study Assessing the Safety, Tolerability and PK of AZD1386 in Healthy Volunteers (NCT00945178) | AstraZeneca | 2009-08-01 |
| AZD5423 Single Ascending Dose Study (NCT00963183) | AstraZeneca | 2009-08-01 |
| Study in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Equivalent Drug Amount to the Body (NCT00957944) | UCB Pharma | 2009-07-01 |
| Pharmacokinetics Of Celecoxib Test Formulations (NCT00925106) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-07-01 |
| The Effect of LipoCol Forte® Capsules on the Pharmacokinetics of Nifedipine After Administering Single-dose Combination to Healthy Subjects (NCT01346657) | Taipei Medical University WanFang Hospital | 2009-07-01 |
| A Pharmacokinetic And QT Study Of CP-751,871 In Healthy Subjects (NCT00926263) | Pfizer | 2009-07-01 |
| A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron. (NCT01284868) | Astellas Pharma Inc | 2009-07-01 |
| Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 in Healthy Volunteers (NCT00940212) | AstraZeneca | 2009-07-01 |
| A Bioequivalence Study Of AG-013736 Tablets In Healthy Volunteers (NCT00905814) | Pfizer | 2009-07-01 |
| Investigation of Dietary Absorptive Capacity of Fructans in Healthy Subjects - A Dose Response Study (NCT00988403) | Augusta University | 2009-06-01 |
| Food Effect Study Of AG-013736 In Healthy Volunteers (NCT00918632) | Pfizer | 2009-06-01 |
| Effects of Substance P Antagonists on Adrenal Secretion (NCT00977223) | University Hospital, Rouen | 2009-06-01 |
| Magnetic Prefrontal Stimulation for Studying the Role of the Cortex in High-level Cognition Processes and Reward System (NCT00912522) | Hadassah Medical Organization | 2009-06-01 |
| A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults (NCT00907322) | Pfizer | 2009-06-01 |
| AZD6088 Single Ascending Dose Study (NCT00931541) | AstraZeneca | 2009-06-01 |
| A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy Subjects (NCT00875030) | Pfizer | 2009-06-01 |
| A Phase I Open-Label Study of the Effects of Tacrolimus and Cyclosporine on CP-690,555 in Healthy Volunteers (NCT00860496) | Pfizer | 2009-06-01 |
| Transient Lower Esophageal Sphincter Relaxations and High Resolution Manometry (NCT00931593) | Hospices Civils de Lyon | 2009-05-01 |
| Evaluation Of The Relative Bioavailability Of PF-04457845 Tablet To Solution Formulation And Food Effect In Healthy Subjects (NCT00918164) | Pfizer | 2009-05-01 |
| Study to Evaluate Single Inhaled Doses of PT001, PT003, PT005 and PT001 Plus PT005 in Healthy Subjects (NCT00893971) | Pearl Therapeutics, Inc. | 2009-05-01 |
| An Open Label, Randomized, Crossover Study To Estimate The Pharmacokinetics And Evaluate The Safety Following A Single Dose Of Azithromycin 2g Extended-Release Powder For Oral Suspension With A 3-Day Dosing Regimen Of Azithromycin 500mg Tablet In Chinese Healthy Male Subjects (NCT00879983) | Pfizer | 2009-05-01 |
| Adverse Effects of RBC Transfusions: A Unifying Hypothesis (NCT00838331) | Emory University | 2009-04-01 |
| AMAP102 - Safety, Tolerability and Pharmacokinetics in Healthy Subjects (NCT00995605) | AnaMar AB | 2009-04-01 |
| Effect of Hyperoxemia on Platelet Function in Healthy Volunteers (NCT01057420) | University of Zurich | 2009-04-01 |
| Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate (NCT02135965) | Pennington Biomedical Research Center | 2009-04-01 |
| Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With Water (NCT00871806) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-04-01 |
| A Study to Investigate the Safety, Tolerability and Pharmacokinetics of OZ439 in Healthy Male and Female Subjects (NCT00928083) | Medicines for Malaria Venture | 2009-04-01 |
| A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults (NCT00855101) | Pfizer | 2009-04-01 |
| A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers (NCT00875628) | Pfizer | 2009-04-01 |
| The Relationship Between Uric Acid and Inflammatory Markers (NCT01323335) | National Institute on Aging (NIA) | 2009-03-31 |
| Study of Prasugrel in Korean Healthy Male Volunteers (NCT01591317) | Eli Lilly and Company | 2009-03-01 |
| Interaction of Otolith Stimulation and Carotid Baroreflex in Humans (NCT02565095) | University Hospital, Caen | 2009-03-01 |
| Biopsy Study for Sculptra (Poly-L-Lactic Acid) (NCT00869687) | Bausch Health Americas, Inc. | 2009-03-01 |
| Gut Hormone Secretion and Macronutrients (NCT00869453) | University of Lausanne | 2009-03-01 |
| A Study to Evaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and Sex (NCT01285596) | Astellas Pharma Inc | 2009-03-01 |
| Multiple Dose Study in Healthy Volunteers to Assess Safety, Pharmacokinetics and Pharmacodynamics of PF 03882845 (NCT00856258) | Pfizer | 2009-03-01 |
| A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin Simultaneously (NCT01297192) | Astellas Pharma Inc | 2009-03-01 |
| Cutaneous DNA Damage Caused by UV-A Irradiation (NCT00864955) | University Hospital, Grenoble | 2009-03-01 |
| A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects (NCT00854659) | Abbott | 2009-03-01 |
| Intravenous Dose-Escalation Study With ETI-204 in Adult Volunteers (NCT00829582) | Elusys Therapeutics | 2009-02-01 |
| Hemin in Healthy Subjects (NCT00882804) | Mayo Clinic | 2009-02-01 |
| The MURDOCK Study Registry and Biorepository Horizon 1.5 (NCT01708408) | Duke University | 2009-02-01 |
| Water- and Salt-homeostasis in Healthy Humans, and in Patients With Heart- or Lung Disease (NCT00830726) | Kolding Sygehus | 2009-02-01 |
| Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men (NCT00850564) | Massachusetts General Hospital | 2009-02-01 |
| A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers (NCT00813241) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-01-01 |
| BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency (NCT01259544) | Meridian Bioscience, Inc. | 2009-01-01 |
| Pharmacokinetic Study of ORM-12741 in Healthy Volunteers (NCT00818740) | Orion Corporation, Orion Pharma | 2009-01-01 |
| ASP8825 - A Study to Investigate the Food Effect on the Pharmacokinetics of ASP8825 (NCT02632331) | Astellas Pharma Inc | 2009-01-01 |
| Study of ASKP1240 After a Single Intravenous Dose at Escalating Dose Levels in Healthy Subjects (NCT01565681) | Astellas Pharma Global Development, Inc. | 2009-01-01 |
| A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis. (NCT00838058) | Pfizer | 2009-01-01 |
| Training Effects on Skeletal Muscle Fatty Acid Metabolism (NCT00786487) | University of Minnesota | 2009-01-01 |
| A Phase 1 Multiple-Dose Escalation and Single Dose (Tablet) Study of PF-04171327 in Healthy Volunteers (NCT00812825) | Pfizer | 2009-01-01 |
| A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04629991 in Healthy Volunteers (NCT00797342) | Pfizer | 2008-12-01 |
| Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain (NCT00788801) | Abbott | 2008-12-01 |
| Comparison of the Cellular and the Humoral Immunogenicity, Safety of Different Trivalent Influenza Vaccines (NCT01119157) | National Centre for Epidemiology, Hungary | 2008-11-01 |
| Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20 (NCT00803972) | Halozyme Therapeutics | 2008-11-01 |
| Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously (NCT00788294) | Pfizer | 2008-11-01 |
| Evaluating the Quality of Different Methods of Obtaining Informed Consent (NCT00794729) | National Institutes of Health Clinical Center (CC) | 2008-10-16 |
| A Study to Evaluate the Possible Effects of Taking Mirabegron While Taking a Contraceptive Pill (NCT01297179) | Astellas Pharma Inc | 2008-10-01 |
| AZD8075 Single Ascending Dose Study (NCT00787072) | AstraZeneca | 2008-10-01 |
| Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition (NCT00780325) | University of Pennsylvania | 2008-10-01 |
| Cumulative Irritation Potential of 828 Ointment (NCT00767455) | Healthpoint | 2008-10-01 |
| A Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Oral Doses Of PF-03716539 In Healthy Adult Subjects (NCT00783484) | Pfizer | 2008-10-01 |
| Contact Sensitization Potential of 828 Ointment (NCT00767676) | Healthpoint | 2008-10-01 |
| Polyphenols and Insulin Resistance (NCT01478841) | University Hospital, Montpellier | 2008-10-01 |
| Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis (NCT00757042) | Amgen | 2008-09-18 |
| Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC (NCT00746733) | Shire | 2008-09-08 |
| Study to Determine the Effect of a Newly Formulated Tetracaine Product PET500 on Penile Skin Sensation (NCT04247230) | Futura Medical Developments Ltd. | 2008-09-03 |